Reply to C. Marchetti et al
- PMID: 36201707
- DOI: 10.1200/JCO.22.01832
Reply to C. Marchetti et al
Comment on
-
Rucaparib Maintenance in Upfront Ovarian Cancer: The Long-Lasting Challenge of Predicting Response to Poly (ADP-ribose) Polymerase Inhibitors.J Clin Oncol. 2023 Feb 1;41(4):935-936. doi: 10.1200/JCO.22.01585. Epub 2022 Oct 6. J Clin Oncol. 2023. PMID: 36201722 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources